“IMP-1 Inhibits Renal Cell Carcinoma 786-O Cell Growth by Targeting EphrinB2 Signaling Pathway”. 2023. Brazilian Journal of Pharmaceutical Sciences 59 (June): e22102. https://doi.org/10.1590/s2175-97902023e22102 .